“I wouldn’t be surprised to see capital flow into medical stocks this year” by Marketing | May 1, 2025 | Market Notes, Media NotesIf A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?
“I was pleased to see Pfizer’s commitment to reducing R&D expenses through prioritizing 4 key R&D engines” by Marketing | Apr 30, 2025 | Market Notes, Media NotesS&P 500 Stock Pfizer Jumps As Cost-Cutting Bolsters Profit
